The one-hour webinar will be offered twice.
- February 6, 2025 11:00 AM ET/ 8:00 AM PT/ 4:00 PM GMT
- February 13, 2025 @ 10:00 AM ET/ 7:00 AM PST/ 3:00 PM GMT
Presentation and Q&A Session
- Introduction to The Oxford-Harrington Rare Disease Centre, a partnership between The University of Oxford and Harrington Discovery Institute
- What is the Oxford-Harrington Rare Disease Scholar Award?
- What types of rare disease projects are best suited to this award?
- How can the award help advance your project towards clinical trials and commercial success?
- Best practices for submitting an application.
Reminder: Applications for this award are due by March 10, 2025.
The Oxford-Harrington Rare Disease Scholar Award accelerates breakthrough academic discoveries into new treatments for rare diseases with an emphasis on neurological disorders, developmental and metabolic disorders, and rare cancers. Other rare genetic indications with high unmet need are also eligible for the award.
Download Award Brochure
Successful applicants will receive:
- Guaranteed grant award of USD$100,000 for US- and Canada-based awardees and £100,000 for UK-based awardees
- One year of therapeutics development support and project management with potential to renew for a second year based on milestones met
- Access to core facilities and infrastructure including oligonucleotide synthesis and screening, small molecule and protein platforms, cell and gene therapy facilities
- Opportunity to compete for acceleration funds up to USD$300,000 / £250,000
- Opportunity to qualify for investment funds up to USD$1,000,000 according to project requirements
- NOTE: IP rights are retained by the awardee or their institution
Important Dates
- Call Opens for Applications
January 15, 2025
- Application Submission Deadline
March 10 at 11:59p ET
- Finalists Contacted for Due Diligence Review
June - July 2025
- Notification of Award
September 2025
For more information: HarringtonDiscovery.org/OHCAward
